Search Results

One-Year Data Published From FORWARD Study of Medtronic's CoreValve Evolut R System

December 3, 2018—Ganesh Manoharan, MD, et al published 1-year outcomes from the international FORWARD study in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2018;11:2326–2334).

European Pivotal Trial Results Published for Medtronic's CoreValve Evolut R TAVR Device

August 27, 2015—In the Journal of American College of Cardiology (JACC): Cardiovascular Interventions, Ganesh Manoharan, MD, et al published findings from a prospective evaluation of the safety and clinical performance of the CoreValve Evolut R transcatheter aortic valve replacement (TAVR) system (Medtronic, plc) in the single-arm, multicenter CE Mark pivotal study for the device in high- or extreme-risk patients with symptomatic aortic valve stenosis (2015;8:1359–1367).

One-Year Data Affirm Performance of Medtronic's CoreValve Evolut R System

October 14, 2015—Medtronic plc announced that 1-year data from the Evolut R CE Study of the CoreValve Evolut R recapturable, self-expanding transcatheter aortic valve replacement (TAVR) system were presented by study investigator Ganesh Manoharan, MD, at TCT 2015, the 27th annual Transcatheter Cardiovascular Therapeutics scientific symposium in San Francisco, California.  The Evolut R CE Study is a prospective, single-arm, multicenter study that enrolled 60 extreme-risk and high-risk patients at six centers in Australia, New Zealand, and the United Kingdom.

Thirty-Day Results Support St. Jude Medical's Portico TAVR System

August 22, 2016—The 30-day safety and performance results from the PORTICO TF EU trial of St.

Safety and Efficacy of Medtronic’s Evolut Pro TAVR System Supported by FORWARD PRO Study

November 24, 2020—The prospective, multinational, multicenter, observational FORWARD PRO study evaluated the clinical performance and safety of the CoreValve Evolut Pro (Medtronic) in standard practice.

Preliminary Data Presented From St. Jude Medical's Portico Heart Valve Study

October 28, 2013—St.

Medtronic's CoreValve Evolut R System Receives CE Mark Approval for 26- and 29-mm Sizes

February 2, 2015—Medtronic plc announced European CE Mark approval of the 26- and 29-mm sizes of its CoreValve Evolut R system, the company’s next-generation self-expanding valve for transcatheter aortic valve replacement (TAVR).

St. Jude Medical's Portico Transcatheter Aortic Heart Valve Receives CE Mark Approval

November 19, 2012—St.

European Trial Begins for St. Jude Medical's Portico TAVI Device

December 13, 2011—St.

FORWARD Clinical Study Begins for Medtronic's Evolut R TAVR System in Real-World Setting

March 7, 2016—Medtronic plc announced that Prof.